|
NIH Postdoctoral Fellow, Texas Tech University Medical School
Ph.D. Biology, Texas Tech University, 1986
M.S. Biology, University of Texas-Pan American, 1982
B.S. Biology, University of Texas-Pan American, 1980
Role of estrogens and androgens in reproduction and cancer
Research
interests
Estrogens and androgens are sex
steroid hormones produced by the adrenal glands
and the gonads. These two hormones have important
roles in normal reproductive processes; however,
they are also implicated in certain abnormal processes,
including hormone-dependent cancers. My laboratory
is studying the function of androgens and estrogens
in normal and pathological processes. One area
of study is on chemical pollutants that mimic
the action of estrogen, so called "environmental
estrogens. We are particularly interested in developing
bioassays for detection of these environmental
estrogens, based on the presence of the biomarker
vitellogenin in the blood of wild animals. Another
area of study is the role of the enzyme steroid
sulfatase in the growth of hormone-dependent cancer.
We are developing steroid sulfatase inhibitors
as potential agents for the treatment of breast
and prostate carcinomas. We are also investigating
the regulation of steroid sulfatase in breast,
bone and ovarian tissues. A third area of emphasis
is the role of androgens in reproduction of female
nonmammalian vertebrates. Androgen levels of females
may be as high as those in males for many species
of reptiles and amphibians, suggesting that androgens
may function in female reproduction. Model systems
used in my laboratory include fish, frogs, turtles,
rats, human placenta, and human breast and prostate
cancer cell lines.
Representative Publications:
1. Selcer, K.W., H. Kabler, J. Sarap, and P.K. Li. Submitted, 2001. Inhibition of steryl sulfatase activity in LNCaP Human Prostate Cancer Cells. Submitted to Steroids.
2. Selcer, K.W. Nagaraja, S., Foret, P., Wagner, D., Williams, L., and Palmer, B.D. 2001. Vitellogenin as a biomarker for estrogenic chemicals: Development of antibodies and primers with broad species applications. In, PCBs: Recent Advances in the Environmental Toxicology and Health Effects, Robertson, R.L., and L.G. Hansen, eds, University of Kentucky Press, Lexington, 416 p.
3. Clemens, J. W., H.L., Kabler, J. L., Sarap, A.R. Beyers, P.K. Li, and K.W. Selcer. 2000. Steroid sulfatase activity in the rat ovary, cultured granulosa cells, and a granulosa cell line. Journal of Steroid Biochemistry and Molecular Biology, 75: 245-252.
4. Kolli, A., G.H. Chu, M.E. Rhodes, K.W. Selcer, and P.K. Li. 1999. Development of (p-O-sulfamoyl)-N-alkanoyl-phenylalkyl amines as non-steroidal estrone sulfatase inhibitors. Journal of Steroid Biochemistry and Molecular Biology 68: 31-40.
5. Chu, G.-H., A. Peters, K.W. Selcer, and P.K. Li. 1999. Synthesis and sulfatase inhibitory activities of (E)- and (Z)-4-hydroxytamoxifen sulfamate. Bioorganic & Medicinal Chemistry Letters 9: 141-144.
6. McNabb, A., C. Schreck, , C. Tyler, P. Thomas, V. Kramer, J. Specker , M. Mayes and K.W. Selcer. 1999. Basic Physiology. In: Reproductive and Developmental Effects of Contaminants in Oviparous Vertebrates (R. Di Giulio and D. Tillitt, eds.). SETAC Press, Pensacola, FL.
7. Selcer, K.W. and J.W. Clemens. 1998. Androgen effects and receptors in subavian species. In: Encyclopedia of Reproduction, Vol. 1 (E. Knobil and J.D. Neill, eds.). Academic Press, San Diego, pp. 207-213.
8. Li, P.K., G.H. Chu, A.M. Peters, and K.W. Selcer. 1998. Development of potent non-estrogenic estrone sulfatase inhibitors. Steroids 63: 425-432.
9. Palmer, B.D., D.L. Pieto, L.K. Huth, and K.W. Selcer. 1998. Vitellogenin as a biomarker for xenobiotic estrogens in an amphibian model system. Environmental Toxicology and Chemistry, 17: 30-36.
10. Selcer, K.W., P.K. Li, and P. Hegde. 1997. Inhibition of estrone sulfatase and breast cancer cell proliferation by nonsteroidal (p-O-sulfamoyl)-N-alkanoyl tyramines. Cancer Research, 57: 1-6.
11. Palmer, B.D., and K.W. Selcer. 1996. Vitellogenin as a biomarker for xenobiotic estrogens. In: Environmental Toxicology and Risk Assessment: Biomarkers and Risk Assessment (5th. Volume), ASTM STP 1306, David A. Bengtson and Diane S. Henshel, Eds., American Society for Testing and Materials, West Conshohocken, PA, p. 3-22.
12. Selcer, K.W., S. Jagannathan, and P.K. Li. 1996. Inhibition of placental estrone sulfatase activity and MCF-7 breast cancer cell proliferation by estrone-3-amino derivatives. Journal of Steroid Biochemistry and Molecular Biology, 59: 83-91.
13. Selcer, K. W. and P. K. Li. 1995. Estrogenicity, antiestrogenicity, and estrone sulfatase inhibition of estrone-3-amine and estrone-3-thiol. Journal of Steroid Biochemistry and Molecular Biology, 52: 281-286.
14. Selcer, K. W. and B. D. Palmer. 1995. Estrogen downregulation of albumin and a 170 kDa protein in the turtle Trachemys scripta. General and Comparative Endocrinology 97: 340-352.
Patents:
1. Derivatives of estra 1,3,5(10)triene-17-one, 3 amino compounds and their use.
Inventors: P.K. Li and K.W. Selcer
US Patent # 5,571,933, reissued as # 5,866,603
Filed 11/17/94, Issued 11/5/96, reissued 2/2/99
2. Steroid sulfatase inhibitors and methods for making and using the same.
Inventors: P.K. Li and K.W. Selcer
US Patent # 5,880,115
Filed 6/30/97, Issued 3/6/99
3. Compounds for the treatment of estrogen-dependent illnesses and methods for making and using the same.
Inventors: P.K. Li and K.W. Selcer
Filed 8/1/98
Approved 1/18/01, Application # 09/164/889
Continuation in part filed 3/24/2000, approved 9/11/2001
US Patent # 6,288,107 B1
Office Phone: (412) 396-5967
Email: selcer@duq.edu
|
